PortViewPortView
Apogee Acquisition Corp logo

Apogee Acquisition Corp (AACPR) Stock Analysis

NASDAQFinancial ServicesShell Companies

$0.19-1.12%
1-year price historyRange $0.14 – $0.21
52-week range$0.19
$0.14$0.23

What Apogee Acquisition Corp does

Apogee Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. [16, 26]

Key metrics

Market cap
$165.37M
Beta
-0.83
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$0.20
200-day avg
$0.20
52-week high
$0.23
52-week low
$0.14
CEO
Jeffrey Andrew Smith

ETFs linked to AACPR

Broad-market and Financial Services sector ETFs an investor holding Apogee Acquisition Corp is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AACPR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AACPR in PortView →

Frequently asked questions

What is the ticker symbol for Apogee Acquisition Corp?
Apogee Acquisition Corp trades under the ticker AACPR on NASDAQ.
Which exchange is AACPR listed on?
AACPR is listed on NASDAQ.
What sector does Apogee Acquisition Corp operate in?
Apogee Acquisition Corp is classified in the Financial Services sector (Shell Companies industry).
How can PortView help analyze AACPR in a portfolio?
PortView shows AACPR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.